Chris Hannay
Chris Hannay is a staff reporter at The Globe and Mail, where he specializes in covering the intricate business of healthcare in Canada. In his reporting, he delves into the complexities and challenges of the fragmented medical records system in the country, highlighting how these issues impact both patients and healthcare providers. With a focus on potential solutions, Hannay explores the benefits of adopting a more interconnected medical record system to improve efficiency and access to information.
Not in the pool (under ¢1).
Recent news mentions
Chris Hannay covers the business of health care for the Globe and Mail.
The bureaucracy slowing down access to life-saving drugs
Canada· 2025-11-23
Chris Hannay discusses the arrangement between Manulife and Shoppers Drug Mart.
Canada’s unemployment rate climbs, Ottawa to delay EV mandate and a Manulife-Shoppers agreement: Business and investing stories for the week of Sept. 7Canada· 2025-09-07
Chris Hannay reports that Eli Lilly & Co. has increased prices of its popular diabetes and anti-obesity drug Mounjaro in Canada.
Air Canada flight attendants on strike, China’s new tariff and higher prices for weight-loss drugs in Canada: Business and investing stories for the week of Aug. 17Canada· 2025-08-17
Business reporter Chris Hannay explains the impact of generic versions of Ozempic in Canada.
Trump threatens 35% tariffs, Quebec braces for copper levies and a generic Ozempic is coming to Canada: Business and investing stories for the week of July 13Canada· 2025-07-13
Chris Hannay is a staff reporter at The Globe who covers the business of healthcare.
Canada’s fragmented medical records systemCanada· 2025-04-15